Home » Topics » Regulatory

Regulatory
RSS

First biologic therapy for psoriasis approved by FDA

Feb. 4, 2003

First treatment for acute ischemic stroke cleared for use in Europe

Jan. 29, 2003

Nabi-HB accepted for priority review for use in liver transplantation

Jan. 27, 2003

Amgen submits sBLA for Enbrel in ankylosing spondylitis

Jan. 24, 2003

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Jan. 23, 2003

Lamictal approved for adjunctive use in pediatric partial seizures

Jan. 23, 2003

Asmanex Twisthaler launched in U.K.

Jan. 23, 2003

E.U. approves Taxotere in combination with cisplatin for first-line NSCLC treatment

Jan. 22, 2003

Chiesi's budesonide Modulite pMDI approved in Germany

Jan. 21, 2003

Novartis seeks approval for lower dose of Estalis in Sweden

Jan. 21, 2003

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.